HLTH vs Hospitalar for Exhibitors
Side-by-side data and our editorial take on which conference is the right exhibit investment for your medical device.
By Buzzbox Media · Last reviewed August 3, 2026
If you exhibit medical devices, HLTH and Hospitalar are likely both on your shortlist. Both serve overlapping clinical buyers, but the audience composition, booth economics, and exhibit floor experience differ in ways that materially affect ROI. HLTH draws 12,000 attendees with no booth pricing published by the organizer. Hospitalar draws 91,000 attendees with no booth pricing published by the organizer. Below is the side-by-side data plus our editorial take on which conference fits which kind of exhibitor.
| 9.3 HLTH | 9.5 Hospitalar | |
|---|---|---|
| Score | ||
| Buzzbox Score | 9.3 (Exceptional) | 9.5 (Exceptional) |
| Event Details | ||
| Dates | November 15-18, 2026 | May 19-22, 2026 |
| Location | The Venetian Expo & Convention Center, Las Vegas, NV | Sao Paulo Expo Exhibition & Convention Center, Sao Paulo, Brazil |
| Scale | mega | mega |
| Audience | ||
| Attendees | 12,000 | 91,000 |
| Exhibitors | n/a | n/a |
| Purchasing authority | ~50% | ~55% |
| Effective buyers | 6,000 | 50,050 |
| Costs | ||
| $/sqft | n/a | n/a |
| 10×10 space | n/a | n/a |
| All-in estimate | n/a | n/a |
| Cost per buyer | n/a | n/a |
Why exhibit at HLTH
The dominant US healthcare innovation conference with 12,000+ senior decision-makers, investors, and digital health executives. Turnkey booths with AV included reduce logistical burden. If you are a digital health, AI, or health IT company seeking enterprise health system or payer customers, this is where deals start.
Why exhibit at Hospitalar
The #1 gateway to Latin America's healthcare markets. Brazil alone is the 6th largest medical device market globally. 91,000+ attendees with significant government procurement officers make this essential for companies expanding into LatAm.
Why skip HLTH
Extremely expensive: minimum booth is 10x20 (no 10x10 option), and turnkey pricing with no publicly listed rates suggests $30k+ entry point. Heavily skewed toward digital health and payer innovation, not traditional medical devices. Clinician presence is minimal compared to clinical conferences.
Why skip Hospitalar
Brazil's ANVISA regulatory pathway is complex and slow. Companies without existing Brazilian registration or a local importer/distributor will collect leads they can't convert for 12-24 months. Portuguese-language materials are essential. English-only booths underperform badly.
HLTH publishes no booth pricing we can link to, so no cost is listed for it. See the official HLTH site ↗ for exhibitor details. Hospitalar publishes no booth pricing we can link to, so no cost is listed for it. See the official Hospitalar site ↗ for exhibitor details. Confirm current pricing with each organizer before committing a budget.
Frequently Asked Questions
Does HLTH or Hospitalar have more decision makers?
Hospitalar does, on our estimate: roughly 50,050 effective buyers against about 6,000 at HLTH. Effective buyers multiplies total attendance by the share of attendees who hold purchasing authority, so Hospitalar works out to about 91,000 attendees at roughly 55% authority, and HLTH to about 12,000 at roughly 50%. Both inputs are estimates drawn from organizer reporting and our own exhibitor research, so read the gap as directional rather than exact.
Want to add a third conference to this comparison?
Compare these conferences in our interactive tool →Other conferences you might consider
Buzzbox Media is a medical device advertising agency with over 15 years in medtech. See our conference marketing.